Abstract
Lactulose is currently the drug of choice for the treatment of hepatic encephalopathy. It is, however, only available as a syrup which is contaminated with other sugars. Consequently patients may express aversion to its excessively sweet taste and many experience nausea because of its hyperosmolarity. Lactitol is a disaccharide analogue of lactulose which can be produced as a pure crystalline powder with a low relative sweetness. Theoretically it should have the same therapeutic effects as lactulose but fewer side effects. Five patients with chronic hepatic encephalopathy on maintenance lactulose were monitored clinically, psychometrically, and by measurement of venous blood ammonia, electroencephalogram mean cycle frequency, and cerebral blood flow during three months treatment with lactulose and a similar period on lactitol. Lactitol was at least as efficacious as lactulose but was more acceptable because its cathartic effect was more predictable, its formulation was more convenient and its less sweet taste preferred. Lactitol is the ideal successor to lactulose for treatment of this condition.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bircher J., Bührer M., Franz K., van Velthuijsen J. A. Erstmalige Anwendung von Lactitol in der Behandlung der porto-systemischen Enzephalopathie. Schweiz Med Wochenschr. 1982 Sep 18;112(38):1306–1307. [PubMed] [Google Scholar]
- Bircher J., Müller J., Guggenheim P., Haemmerli U. P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. doi: 10.1016/s0140-6736(66)91573-x. [DOI] [PubMed] [Google Scholar]
- Conn H. O. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis. 1977 Jun;22(6):541–550. doi: 10.1007/BF01072510. [DOI] [PubMed] [Google Scholar]
- Hoyumpa A. M., Jr, Desmond P. V., Avant G. R., Roberts R. K., Schenker S. Hepatic encephalopathy. Gastroenterology. 1979 Jan;76(1):184–195. [PubMed] [Google Scholar]
- Kaupke C., Sprague T., Gitnick G. L. Hypernatremia after the administration of lactulose. Ann Intern Med. 1977 Jun;86(6):745–746. doi: 10.7326/0003-4819-86-6-745. [DOI] [PubMed] [Google Scholar]
- Kendrick D. C., Gibson A. J., Moyes I. C. The Revised Kendrick Battery: clinical studies. Br J Soc Clin Psychol. 1979 Sep;18(3):329–340. doi: 10.1111/j.2044-8260.1979.tb00343.x. [DOI] [PubMed] [Google Scholar]
- Liehr H., Englisch G., Rasenack U. Lactulose--a drug with antiendotoxin effect. Hepatogastroenterology. 1980 Oct;27(5):356–360. [PubMed] [Google Scholar]
- Wyper D. J., Lennox G. A., Rowan J. O. Two minute slope inhalation technique for cerebral blood flow measurement in man. 1. Method. J Neurol Neurosurg Psychiatry. 1976 Feb;39(2):141–146. doi: 10.1136/jnnp.39.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zeegen R., Drinkwater J. E., Dawson A. M. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J. 1970 Jun 13;2(5710):633–636. doi: 10.1136/bmj.2.5710.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Velthuijsen J. A. Food additives derived from lactose: lactitol and lactitol palmitate. J Agric Food Chem. 1979 Jul-Aug;27(4):680–686. doi: 10.1021/jf60224a040. [DOI] [PubMed] [Google Scholar]